Azora Therapeutics, Inc. (NASDAQ:AZR) IPO
IPO
Went public as ADIAL PHARMACEUTICALS, INC. Priced at US$5.00 a unit on Jul 26, 2018.
- Price
- US$5.00 a unit
- Units offered
- 1,464,000 units
- Offering size
- US$7.3 million
- Underwriters' option
- Up to 219,600 more units
- Listing
- ADIL on the Nasdaq Capital Market
- Underwriters
- Joseph Gunnar & Co., Dawson James Securities, Inc. · In the order on the cover
- Units delivered
- On or about Jul 31, 2018
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 12, 2017 |
| Filed publicly | Sep 7, 2017 |
| Amended 8 times | Newest Jul 10, 2018 |
| Shares registered with an exchange | Dec 11, 2017 |
| Declared effective by the SEC | Jul 26, 2018 |
| Final prospectus, with the price | Jul 30, 2018 |
Filings
From the cover of the final prospectus (424B4) filed Jul 30, 2018